Register entry
S.A.L.A.R.S. SOCIET AZIONARIA LABORATORI ALCALOIDI RIFORNIMENTI SANITARI S.P.A.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 bulk ingredient. By marketing category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 2.
| Dosage form | NDCs |
|---|---|
| powder | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| s.a.l.a.r.s. societ azionaria laboratori alcaloidi rifornimenti sanitari s.p.a. | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Naltrexone | powder | 69641-0002BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Naltrexone Hydrochloride | powder | 69641-0001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Compare
Other companies listing naltrexone
- SpecGx LLC5 sites · 237 NDC
- NURAY CHEMICALS PRIVATE LIMITED1 site · 105 NDC
- STHREE CHEMICALS PRIVATE LIMITED1 site · 52 NDC
- Arevipharma GmbH1 site · 13 NDC
- Saneca Pharmaceuticals a.s.1 site · 6 NDC
- Amneal Pharmaceuticals NY LLC0 sites · 337 NDC
Enquiry
Common questions
- Is S.A.L.A.R.S. SOCIET AZIONARIA LABORATORI ALCALOIDI RIFORNIMENTI SANITARI S.P.A. FDA approved?
- S.A.L.A.R.S. SOCIET AZIONARIA LABORATORI ALCALOIDI RIFORNIMENTI SANITARI S.P.A. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does S.A.L.A.R.S. SOCIET AZIONARIA LABORATORI ALCALOIDI RIFORNIMENTI SANITARI S.P.A. make?
- 2 products are listed under S.A.L.A.R.S. SOCIET AZIONARIA LABORATORI ALCALOIDI RIFORNIMENTI SANITARI S.P.A. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.